Verapamil modulates NFAT2 to inhibit tumor growth and potentiates PD1ab immune checkpoint inhibitor therapy in cervical cancer treatment

IF 2.6 4区生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY

Journal of Receptors and Signal Transduction Pub Date : 2023-12-09 DOI:10.1080/10799893.2023.2291562

Yao-Qing Liao, Bin-Bo Fang, Qing-Xia Wu, Wei-Ying Dong, Guan-Ming Deng

引用次数: 0

Abstract

Current evidence suggests a high co-prevalence of hypertension and cervical cancer. Accordingly, blood pressure control is indicated during anti-tumor drug therapy in this patient population. Over ...

查看原文本刊更多论文

维拉帕米调节 NFAT2 以抑制肿瘤生长，并增强 PD1ab 免疫检查点抑制剂治疗宫颈癌的效果

目前的证据表明，高血压与宫颈癌的共患病率很高。因此，这类患者在接受抗肿瘤药物治疗期间应控制血压。超过 ...

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Receptors and Signal Transduction 生物-生化与分子生物学

CiteScore

6.60

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Journal of Receptors and Signal Tranduction is included in the following abstracting and indexing services: BIOBASE; Biochemistry and Biophysics Citation Index; Biological Abstracts; BIOSIS Full Coverage Shared; BIOSIS Previews; Biotechnology Abstracts; Current Contents/Life Sciences; Derwent Chimera; Derwent Drug File; EMBASE; EMBIOLOGY; Journal Citation Reports/ Science Edition; PubMed/MedLine; Science Citation Index; SciSearch; SCOPUS; SIIC.